ALIAS


High-Dose Albumin Therapy for
Neuroprotection in Acute Ischemic Stroke
PI: Myron Ginsberg, MD - University of Miami
Status: enrolling, current NIH funding for the ALIAS Phase III Trial extends to May 2010



For more information on ALIAS, please click here.